REGENXBIO Inc.RGNXNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank17
3Y CAGR-41.6%
5Y CAGR-22.9%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-41.6%/yr
vs +0.4%/yr prior
5Y CAGR
-22.9%/yr
Recent deceleration
Acceleration
-42.0pp
Decelerating
Percentile
P17
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$102.73M-60.4%
2024$259.65M-16.7%
2023$311.74M-39.6%
2022$516.20M-32.5%
2021$764.30M+102.3%
2020$377.75M-16.1%
2019$450.20M-11.5%
2018$508.85M+178.0%
2017$183.03M+13.2%
2016$161.74M-